Windtree Therapeutics (WINT) announced the appointment of Leanne Kelly to its board of directors. Kelly has served as GRI Bio’s Chief Financial Officer since April 2023.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree lauches new corporate strategy to become revenue generating biotech
- Windtree Therapeutics announces presentation highlighting istaroxime
- Windtree Therapeutics announces new istaroxime patent filing
- Windtree Therapeutics announces partnership with New Growth Advisors
- Windtree Therapeutics Reports Q3 2024 Financial Results